Wanbangde Pharmaceutical Holding Group Co Ltd (002082) - Total Assets
Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) holds total assets worth CN¥4.55 Billion CNY (≈ $666.34 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Wanbangde Pharmaceutical Holding Group C (002082) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Wanbangde Pharmaceutical Holding Group Co Ltd - Total Assets Trend (2003–2025)
This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See what is Wanbangde Pharmaceutical Holding Group C's book value for net asset value and shareholders' equity analysis.
Wanbangde Pharmaceutical Holding Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Wanbangde Pharmaceutical Holding Group Co Ltd's total assets of CN¥4.55 Billion consist of 37.7% current assets and 62.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.5% |
| Accounts Receivable | CN¥619.08 Million | 14.1% |
| Inventory | CN¥232.67 Million | 5.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥665.00 Million | 15.1% |
| Goodwill | CN¥128.86 Million | 2.9% |
Asset Composition Trend (2003–2025)
This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Wanbangde Pharmaceutical Holding Group C stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wanbangde Pharmaceutical Holding Group Co Ltd's current assets represent 37.7% of total assets in 2025, a decrease from 42.8% in 2003.
- Cash Position: Cash and equivalents constituted 12.5% of total assets in 2025, down from 12.7% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 15.1% of total assets.
Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Total Assets
Key competitors of Wanbangde Pharmaceutical Holding Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
China | CN¥2.30 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
China | CN¥925.41 Million |
|
Jw Pharmac
KO:001060
|
Korea | ₩605.27 Billion |
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩449.14 Billion |
Wanbangde Pharmaceutical Holding Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 1.50 | 2.31 |
| Quick Ratio | 1.09 | 1.31 | 2.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥347.43 Million | CN¥580.37 Million | CN¥1.25 Billion |
Wanbangde Pharmaceutical Holding Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Wanbangde Pharmaceutical Holding Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.72 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 1.5% |
| Total Assets | CN¥4.39 Billion |
| Market Capitalization | $895.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wanbangde Pharmaceutical Holding Group Co Ltd's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Wanbangde Pharmaceutical Holding Group Co Ltd's assets grew by 1.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
The table below shows the annual total assets of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.39 Billion ≈ $642.58 Million |
+1.48% |
| 2024-12-31 | CN¥4.33 Billion ≈ $633.23 Million |
+0.72% |
| 2023-12-31 | CN¥4.30 Billion ≈ $628.69 Million |
+1.91% |
| 2022-12-31 | CN¥4.22 Billion ≈ $616.88 Million |
-3.56% |
| 2021-12-31 | CN¥4.37 Billion ≈ $639.67 Million |
-22.80% |
| 2020-12-31 | CN¥5.66 Billion ≈ $828.57 Million |
+48.99% |
| 2019-12-31 | CN¥3.80 Billion ≈ $556.14 Million |
+33.57% |
| 2018-12-31 | CN¥2.85 Billion ≈ $416.37 Million |
+35.49% |
| 2017-12-31 | CN¥2.10 Billion ≈ $307.30 Million |
+26.63% |
| 2016-12-31 | CN¥1.66 Billion ≈ $242.68 Million |
+2.54% |
| 2015-12-31 | CN¥1.62 Billion ≈ $236.66 Million |
+4.27% |
| 2014-12-31 | CN¥1.55 Billion ≈ $226.96 Million |
+0.13% |
| 2013-12-31 | CN¥1.55 Billion ≈ $226.66 Million |
-1.12% |
| 2012-12-31 | CN¥1.57 Billion ≈ $229.23 Million |
+8.31% |
| 2011-12-31 | CN¥1.45 Billion ≈ $211.64 Million |
+9.85% |
| 2010-12-31 | CN¥1.32 Billion ≈ $192.66 Million |
+17.66% |
| 2009-12-31 | CN¥1.12 Billion ≈ $163.74 Million |
+9.51% |
| 2008-12-31 | CN¥1.02 Billion ≈ $149.52 Million |
+10.15% |
| 2007-12-31 | CN¥927.63 Million ≈ $135.74 Million |
+8.93% |
| 2006-12-31 | CN¥851.57 Million ≈ $124.61 Million |
+28.69% |
| 2005-12-31 | CN¥661.73 Million ≈ $96.83 Million |
+58.82% |
| 2004-12-31 | CN¥416.66 Million ≈ $60.97 Million |
+59.29% |
| 2003-12-31 | CN¥261.57 Million ≈ $38.28 Million |
-- |
About Wanbangde Pharmaceutical Holding Group Co Ltd
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascul… Read more